Mark Asset Management LP Denali Therapeutics Inc. Transaction History

Mark Asset Management LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$29.0 - $47.27 $1.17 Million - $1.91 Million	-40,370 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$42.59 - $55.02 $845,028 - $1.09 Million	19,841 Added 96.65%	40,370 $1.8 Million
Q3 2021 Nov 15, 2021	SELL	$48.48 - $78.23 $887,668 - $1.43 Million	-18,310 Reduced 47.14%	20,529 $1.04 Million
Q2 2021 Aug 16, 2021	SELL	$50.3 - $78.44 $3.68 Million - $5.73 Million	-73,080 Reduced 65.3%	38,839 $3.05 Million
Q1 2021 May 17, 2021	SELL	$53.8 - $81.53 $3.23 Million - $4.9 Million	-60,121 Reduced 34.95%	111,919 $6.39 Million
Q4 2020 Feb 16, 2021	SELL	$36.89 - $93.56 $272,580 - $691,314	-7,389 Reduced 4.12%	172,040 $14.4 Million
Q3 2020 Nov 16, 2020	SELL	$23.13 - $38.84 $24,725 - $41,519	-1,069 Reduced 0.59%	179,429 $6.43 Million
Q2 2020 Aug 14, 2020	BUY	$16.01 - $28.82 $287,795 - $518,068	17,976 Added 11.06%	180,498 $4.36 Million
Q1 2020 May 15, 2020	BUY	$14.2 - $27.98 $1.36 Million - $2.69 Million	95,965 Added 144.18%	162,522 $2.85 Million
Q4 2019 Feb 14, 2020	SELL	$14.4 - $19.99 $33,220 - $46,116	-2,307 Reduced 3.35%	66,557 $1.16 Million
Q3 2019 Nov 14, 2019	SELL	$15.32 - $21.92 $25,553 - $36,562	-1,668 Reduced 2.36%	68,864 $1.06 Million
Q1 2019 May 13, 2019	BUY	$17.99 - $24.65 $910,869 - $1.25 Million	50,632 Added 254.43%	70,532 $1.64 Million
Q4 2018 Feb 12, 2019	BUY	$13.88 - $21.75 $276,212 - $432,825	19,900 New	19,900 $411,000

228

120M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.12B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Mark Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Mark Asset Management LP with notifications on news.